Venue: Prescrire’s meeting rooms, 68-70 Boulevard Richard Lenoir, 75011 Paris
HOW CAN WE PREVENT THAT DRUGS DO MORE HARM THAN GOOD…
AGENDA
| Thursday, 10 October 2019 - morning |
9:00-10:00 | Registration for members – Meet together and coffee & tea |
| 10:00-12:30 | ISDB internal affairs Welcome by ISDB President and Prescrire (Pierre Chirac) - Call for new committee candidates
- Financial matters: accounting report, membership subscription status (Luis Carlos Saiz Fernandez, ISDB treasurer)
- Membership: update on new and no-longer-members, presentation of new members
- Report from the ISDB Committee on main activities since 2016
- Review of bulletin quality (Maria Font, Infofarma, Italy)
- Update on implementation of new ISDB conflict of interest policy (Dick Bijl)
- ISDB website update (Dick Bijl)
- Clinical trials working group (Nuria Homedes, USA)
- HTA - advocacy group (Rita Kessler, Prescrire, France)
- Barbara Mintzes (University of Sydney) Comparison of post-market safety warnings of FDA, MHRA/EMA, Health Canada and TGA
Moderator: Dick Bijl (ISDB President) |
| 12:30-14:00 | Registration for non-members – Lunch on the spot |
| Thursday, 10 October 2019 - afternoon |
14:00-15:30 | Drug regulatory environment, quality of the evidence needed Introduction: Dick Bijl (ISDB President) talking about the challenge Speakers: - Jordi Llinares (Head or Scientific and Regulatory Management at the European Medicines Agency, EMA): Presubmission contacts with marketing authorisation applicants and Priority Medicines scheme (PRIME).
- Claudia Wild (Director of Ludwig Bolzmann Institute for HTA, Austria): Oncologic drugs: little evidence about clinical benefits at time of approval, what is known shows marginal effectiveness of most drugs.
- Sidney Wolfe (Worst Pills – Best Pills, USA): Breaking through Corporate/Government Duopoly of Power
Discussion: ISDB members’ experience and recommendations – What kind of evidence ISDB members want from regulators? Moderator: Christophe Kopp (Prescrire, France) |
| 15:30-16:00 | Coffee & tea break |
| 16:00-17:30 | Andrew Herxheimer Memorial Session: Evidence-based deprescribing: a challenge for independent drug bulletins Speakers: - Alan Cassels (Therapeutics Initiative, Canada)
- Dee Mangin (TaperMD, Canada)
- Anne Sophie Parent (AGE platform, Europe)
Discussion Moderator: Thierry Christiaens (Folia Pharmacotherapeutica, Belgium) |
| 19:00 | Dinner at Molly’s 91 rue de Charenton |
Friday, 11 October 2019 - morning |
| 9:00 -10:30 | Conflicts of interest (CoI) and elaboration of trusted evidence:
the way forward The Cochrane affair and other CoI issues: lessons and consequences for ISDB bulletins Speakers: - Zoé Friedmann (Universities Allied for Essential Medicines, UAEM Germany): CoI and medical students
- Juan Erviti (Cochrane Hypertension Group, DTB Navarre)
- Peter Gøtzsche (Institute for Scientific Freedom, Denmark)
Discussion Moderator: Jörg Schaaber (Pharma-Brief, Germany) |
| 10:30 -11:00 | Coffee & tea break |
| 11:00 -12:30 | How to deal with Big Data? Pros and Cons Speakers: - Gerd Antes (Ex Director, Cochrane Germany): Big Data – marketing driven hype versus science based progress, where are we going?
- Rita Banzi (Head of the Center for Health Regulatory Policies – Mario Negri Institute, Italy): Real world data for regulatory decisions
Discussion Moderator: Rita Kessler (Prescrire, France) |
| 12:30 -14:00 | Lunch |
Friday, 11 October 2019 - afternoon |
| 14:00 -16:00 | Pharmacovigilance and lessons from health scandals Speakers: - Juan Laporte (Fundació Institut Català de Farmacologia - Founder and director of Butlletí Groc since 1984)
- David Healy (RxISK - Professor of Psychiatry at Bangor University (UK)
- Adriane Fugh-Berman (Georgetown University, Washington DC/ PharmedOut) opioid crisis USA
- Marine Martin (President of Association of Parents of Children with Anticonvulsant Syndrome - APESAC France)
Discussion Moderator: Maria Font (Infofarma, Italy) |
| 16:00-16:30 | Coffee & tea break and walking around the posters |
| 16:30-18:00 | Drug Information in the news and new media: a challenge for Independent quality drug information Speakers: - Alan Cassels (Therapeutics Initiative, Canada)
- Anna Coretchi (Medex-Corsum, Moldova)
Discussion Moderator: Barbara Mintzes (University of Sydney, Australia) |
Saturday, 12 October 2019 |
| 9:00-10:00 | Drug market in the global South: a challenge for ISDB Speakers: - Martín Cañas (Argentina), editor of Folia Doc, Medical Federation of Buenos Aires Province bulletin, co-founder of the Latin America and Caribbean Drug information centers Network
- Carlos Duran (Excellencis Ecuador), editor of the Ecuadorian Therapeutic Formulary
- Gopal Dabade (SANJEEVINI bulletin, India), cofounder and president of Drug Action Forum – Karnataka (DAF-K), member of All India Drug Action Network (AIDAN)
Discussion Moderator: Benito Marchand (Excellencis Ecuador) |
| 10:00-10:30 | Coffee & tea break |
| 10:30-12:00 | ISDB internal affairs - ISDB on the map: news from the regions
- Canada: 25 years Therapeutics Initiative
- EU: new EU Commission and Parliament: perspectives, working with other organisations
- Other regions
- Results from meeting and discussion of ISDB priorities and work programme
- Election of new Committee
- Closure of the meeting
|
| 12:00-14:00 | Lunch and Meeting of the new Committee |
| 14:30 | End of General Assembly |
